Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 3

EFL070 – Dosing Strategies for Remission in Graves Disease

For our 70th episode, we review a paper that tries to improve our understanding of remission in Graves’ disease. Long-term thionamide treatm

Common medication for lung cancer symptoms found to limit effectiveness of cancer treatment

LOS ANGELES — Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer patients

EFL073 - Infrequent Zoledronate in Low Fracture Risk

For our 73rd episode and the start of the seventh season, we review a recent study examining the long-term anti-fracture efficacy of infrequ

<![CDATA[Relapsed/Refractory Multiple Myeloma: Interpreting MonumenTAL-3 Efficacy and Safety Findings]]>

Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy

STUDIO CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Study results from the randomized, prospective phase III ENDURANCE (E1A11) trial, des

EFL020 - Zoledronate to Maintain BMD Gains After Denosumab

Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center, as he talks with Amal Shibli-Rahhal, MD, from University of Iowa